Markets:

Overview

News

Currencies

International

Treasuries

Bayer Ag ADR (OP:BAYRY)

10.95 -0.16 (-1.45%)

Streaming Delayed Price Updated: 1:07 PM EDT, May 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag ADR

< Previous 1 2 3 4 5 6 7 8 9 Next >

Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now? ↗

May 25, 2026

The stock looks cheap, but appearances can be deceiving.

Via The Motley Fool

Topics Artificial Intelligence

ASCO 2026: Bayer to Present New Data Across Oncology Portfolio

May 21, 2026

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease

May 21, 2026

From Bayer

Via Business Wire

Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

May 19, 2026

From Bayer

Via Business Wire

U.S. FDA Grants Priority Review to Supplemental New Drug Application for HYRNUO® (sevabertinib) Under Investigation as a First-Line Treatment of HER2-Mutated Non-Small Cell Lung Cancer

May 18, 2026

From Bayer

Via Business Wire

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

May 15, 2026

From Bayer

Via Business Wire

Bayer Introduces Midol® in Motion, Empowering Menstruators to Find PMS Relief Through Movement

May 15, 2026

From Bayer

Via Business Wire

Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities

May 13, 2026

From Bayer

Via Business Wire

Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis

May 07, 2026

From Bayer

Via Business Wire

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline

May 06, 2026

From Bayer

Via Business Wire

Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STROKE Trial of Asundexian

April 29, 2026

From Bayer

Via Business Wire

New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing

April 29, 2026

From Bayer

Via Business Wire

Record-Breaking US Soybean Planting Pace Clouds Futures Market

April 15, 2026

The United States Department of Agriculture (USDA) sent ripples through the commodities markets this week with the release of its latest Crop Progress report, revealing that U.S. soybean planting has...

Via MarketMinute

Topics Economy Energy World Trade

Midwest Planting Delays Loom as NOAA Predicts Heavy April Rains

April 13, 2026

As the mid-April sun typically signals the start of the heavy planting season across the American heartland, the 2026 season is proving to be a frustrating exercise in patience. Farmers across the Corn...

Via MarketMinute

USDA Stuns Markets as April WASDE Raises Farm Gate Prices Amid Domestic Supply Crunch

April 10, 2026

The United States Department of Agriculture (USDA) sent shockwaves through the agricultural sector this morning with the release of the April 2026 World Agricultural Supply and Demand Estimates (WASDE)...

Via MarketMinute

Topics Economy Energy

Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

March 31, 2026

From Bayer

Via Business Wire

Multiplatinum Rapper, Actor Ludacris Partners with One A Day® to Help People Realize that Health Does Not Need to Be Ludacris

March 26, 2026

From Bayer

Via Business Wire

The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush

March 18, 2026

As of March 18, 2026, the corporate landscape has undergone a radical transformation. The era of the sprawling global conglomerate, once the gold standard of industrial stability, is rapidly giving way...

Via MarketMinute

Topics Artificial Intelligence Economy

KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease

March 16, 2026

From Bayer

Via Business Wire

New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments

March 04, 2026

From Bayer

Via Business Wire

The Section 122 Pivot: How a 10% Global Tariff is Reshaping the 2026 Market Landscape

March 03, 2026

The global financial markets have entered a period of profound "legalized volatility" following the White House’s emergency invocation of Section 122 of the Trade Act of 1974. This move, triggered by a...

Via MarketMinute

Topics Economy Electric Vehicles Government

The Strategic Crossroads of FMC Corporation: A 2026 Research Deep Dive

March 03, 2026

Date: March 3, 2026 Introduction FMC Corporation (NYSE: FMC) currently finds itself at one of the most pivotal junctures in its 140-year history. Once a darling of the agricultural sector known for its...

Via Finterra

Topics Economy Intellectual Property World Trade

The Great Grain Pivot: USDA Forecasts Record Soy Surge as Corn Retreats in 2026

March 02, 2026

The American agricultural landscape is undergoing a massive structural shift as the 2026 planting season approaches. According to the U.S. Department of Agriculture's (USDA) 102nd Agricultural Outlook...

Via MarketMinute

Topics Energy

Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

February 27, 2026

From Bayer

Via Business Wire

Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases

February 26, 2026

From Bayer

Via Business Wire

European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO

February 23, 2026

In a landmark decision for the cardiovascular treatment landscape, the European Commission (EC) officially granted marketing authorization to Cytokinetics, Inc. (Nasdaq: CYTK) on February 17, 2026, for...

Via MarketMinute

Topics Intellectual Property

Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA

February 23, 2026

From Bayer

Via Business Wire

Bayer's $7.25 Billion Roundup Settlement: A 21-Year Plan for Certainty

February 18, 2026

Bayer AG (OTC: BAYRY) has announced a sweeping $7.25 billion proposed class action settlement aimed at resolving the vast majority of its remaining U.S. litigation involving the weedkiller Roundup....

Via MarketMinute

Topics Lawsuit

Uncle Sam’s $44.36 Per Acre Gamble: How Government Intervention is Distorting the 2026 Planting Season

February 18, 2026

As the 2026 planting season approaches, American farmers are facing a paradox of record-low commodity prices and unprecedented government support. The centerpiece of this intervention is the newly...

Via MarketMinute

Topics Economy

German Pharma Giant Bayer Proposes $7.25 Billion Settlement Over Monsanto's Roundup Cancer Claims In US ↗

February 18, 2026

Bayer AG (OTC: BAYRY) on Tuesday proposed a $7.25 billion settlement to resolve thousands of U.S. lawsuits claiming that its weedkiller Roundup causes cancer. The product was originally made by...

Via Benzinga

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.